ClinicalTrials.govpublic full text
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
small cell lung cancer ( sclc ), extensive stage small cell lung cancer (es-sclc), atezolizumab, durvalumab, sactizumab govetican, small cell lung cancer, sclc, es-sclc, lung cancer, extensive stage, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 800663
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.